Rentschler Biotechnologie: Press Releases

Rentschler announces 4th Laupheim Biotech Days taking place in June 2016
Wednesday, January 20, 2016 The Laupheim Biotech Days – formally known as Laupheimer Zelltage – provide a unique platform for the international exchange of knowledge, ideas and expertise. Held every two years,...

Rentschler and Leukocare announce strategic alliance and equity investment
Thursday, February 02, 2017 Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance under which Leukocare will become the specialised technology partner and...

Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities
Tuesday, June 13, 2017 Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent...

Rentschler Biotechnologie GmbH announces transition into a European corporation called Rentschler Biopharma SE
Wednesday, October 04, 2017 Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that the Company has successfully...

Rentschler Biopharma SE appoints international biopharma expert Dr Ralf Otto as chief operating officer
Wednesday, January 31, 2018 Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, today appointed Dr. Ralf Otto (46) as chief operating officer...

Rentschler Biopharma SE appoints Federico Pollano as senior vice-president, business development
Wednesday, February 28, 2018 Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, today announced that Federico Pollano (55) has joined the Company...

Rentschler Biopharma SE and Leukocare AG report successful first year of unique strategic alliance
Friday, March 09, 2018 Rentschler Biopharma SE and Leukocare AG today reported on the successful first year of their unique strategic alliance.


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.